US 10898585
Gene therapy for AADC deficiency
granted A61KA61K31/4515A61K31/5513
Quick answer
US patent 10898585 (Gene therapy for AADC deficiency) held by PTC THERAPEUTICS, INC. expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/4515, A61K31/5513, A61K48/00, A61K48/005